Rationale for the design of an oncology trial using a generic targeted therapy multi‑drug regimen for NSCLC patients without treatment options (Review)
about
Breaking the crosstalk of the cellular tumorigenic network: Hypothesis for addressing resistances to targeted therapies in advanced NSCLC.Multifunctional Nanomaterials and Their Applications in Drug Delivery and Cancer Therapy.Resveratrol inhibits the proliferation of A549 cells by inhibiting the expression of COX-2.
P2860
Rationale for the design of an oncology trial using a generic targeted therapy multi‑drug regimen for NSCLC patients without treatment options (Review)
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rationale for the design of an ...... out treatment options (Review)
@en
Rationale for the design of an ...... ents without treatment options
@nl
type
label
Rationale for the design of an ...... out treatment options (Review)
@en
Rationale for the design of an ...... ents without treatment options
@nl
prefLabel
Rationale for the design of an ...... out treatment options (Review)
@en
Rationale for the design of an ...... ents without treatment options
@nl
P2860
P921
P356
P1433
P1476
Rationale for the design of an ...... out treatment options (Review)
@en
P2093
Stefan Langhammer
P2860
P304
P356
10.3892/OR.2013.2631
P5008
P577
2013-07-22T00:00:00Z